glp-1 gi obstruction lawsuit in west virginia residents struggle to afford weight loss drugs after state ends subsidy program The hidden risks of GLP-1

What GLP-1 Medications Actually Do to Your Body GLP-1 (glucagon-like peptide-1) receptor agonists work by: Suppressing appetite and increasing feelings of fullness Slowing digestion so you feel satisfied longer Regulating blood sugar and insulin response Originally developed for type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro) are now widely prescribed for weight loss and the WHO formally recognises them as valid obesity treatments

The other four compound the effect

Making lifestyle adjustments is essential to reinforce the medications effects and address the behavioral aspects of weight management

The Bottom Line Current evidence suggests that tirzepatide is unlikely to transfer into breast milk in meaningful amounts

Here are some non-drug treatments that can help: Dietary Changes: Following a healthy diet is crucial for managing diabetes